(MedPage Today) -- "Sneaky" senescent cells that promote treatment resistance could prove to be a target for new lung cancer therapies, researchers said. (UCSF Health, Cell Stem Cell)
British scientists, who developed the 'smart bra', believe the tech will detect tumours as small as 5mm, which may be missed in between mammogram screenings.
(MedPage Today) -- The FDA approved pertuzumab-dpzb (Poherdy) as the first biosimilar for its reference product Perjeta, a monoclonal antibody commonly used in standard regimens for HER2-positive breast cancer.
Former Kent policewoman Shanice Bennett is raising money to fuel her bucket list wishes as she waits to find out how long she has left following her breast cancer diagnosis
James Wild MP has joined Breast Cancer Now in Parliament for the charity’s flagship fundraising campaign, wear it pink, and to show support for everyone affected by breast cancer.Now in its 24th year, wear it pink has raised over £43…
A naturally occurring protein that tends to be expressed at higher levels in breast cancer cells boosts the effectiveness of some anticancer agents, including doxorubicin, one of the most widely used chemotherapies, and a preclinical drug…
A naturally-occurring protein that tends to be expressed at higher levels in breast cancer cells boosts the effectiveness of some anticancer agents, including doxorubicin, one of the most widely used chemotherapies, and a preclinical drug…
Cancer Center at Illinois (CCIL) Program Leader Erik Nelson's lab made an important discovery about the relationship between cholesterol and breast cancer progression with crucial implications for breast cancer therapeutics.
FORMER Winter Olympian Surya Bonaly has revealed that her medals were stolen from her home as she cared for her cancer-stricken mother. Frenchwoman Bonaly, who herself is battling breast cancer, is now based in Las Vegas. The 51-year-old…
Cancer Center at Illinois (CCIL) Program Leader Erik Nelson's lab made an important discovery about the relationship between cholesterol and breast cancer progression with crucial implications for breast cancer therapeutics.
Harvard University cancer researcher Joan Brugge is speaking out against the termination of funding by the Trump administration, which has allegedly affected her work.
(MedPage Today) -- Despite tremendous advances in diagnosis, treatment, and survival, breast cancer remains the most common type of cancer in the U.S., with an estimated 317,000 new cases in 2025. The disease burden drives the search for…
(MedPage Today) -- The DESTINY-Breast11 (DB-11) and DESTINY-Breast05 (DB-05) trials, presented at the European Society for Medical Oncology (ESMO) congress, showed that the inclusion of neoadjuvant or adjuvant trastuzumab pathologic…
When researchers look for potential cancer therapy targets, they typically go after protein-coding genes that participate in disease progression. Disrupt them and negate whatever role they play in cancer's development or spread.